8
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Tumor cell autophagy as an adaptive response mediating resistance to treatments such as antiangiogenic therapy.

      Cancer research
      Adaptation, Biological, Angiogenesis Inhibitors, therapeutic use, Animals, Antineoplastic Agents, Autophagy, drug effects, Chloroquine, pharmacology, Drug Resistance, Neoplasm, Humans, Neoplasms, drug therapy, metabolism, Neovascularization, Pathologic, Tumor Microenvironment

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Autophagy is a lysosomal degradation pathway that can sequester cytosolic material, including organelles, nonspecifically in a process called nonselective macroautophagy, or target specific protein aggregates designated for destruction in a process called selective autophagy. Autophagy is one mechanism that enables tumor cells to survive stressors in the tumor microenvironment, as well as injuries caused by treatments such as chemotherapy and radiation therapy. The complexity of the role of autophagy in cancer is underscored by evidence that autophagy can allow premalignant cells to escape the genotoxic stress and inflammation that promote tumorigenesis, and that some tumor cells exhibit loss of autophagy capacity altogether through molecular mechanisms that have not yet been defined. Efforts to understand and modulate the autophagy pathway will be crucial to maximize the full therapeutic potential of cancer therapies that are currently hindered by tumor cell autophagy as a resistance mechanism. ©2012 AACR.

          Related collections

          Author and article information

          Comments

          Comment on this article